Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ran Xu

Showing results (61-70 of 1,051) with videos related to

Pageof 106
Sort By:
Aging|March 13, 2021
A novel protein ubiquitination-related five-gene signature predicts overall survival in patients with lung adenocarcinomaRan Xu, Tong Lu, Jun Wang, et al.
The Canadian Journal of Cardiology|May 13, 2021
IL-18 Promotes Erythrophagocytosis and Erythrocyte Degradation by M1 Macrophages in a Calcific MicroenvironmentRan Xu, Dan Zhu, Jianghong Guo, et al.
Plos One|November 16, 2017
The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysisYingcheng Wu, Ran Xu, Keren Jia, et al.
Frontiers in Immunology|October 18, 2023
Effects of inflammation on myopia: evidence and potential mechanismsRan Xu, Jing Zheng, Longqian Liu, et al.
Frontiers in Cellular and Infection Microbiology|October 13, 2012
Human gut microbiota: dysbiosis and manipulationDongqian Shen, Chuan Liu, Ran Xu, et al.
Frontiers in Microbiology|August 8, 2022
Therapeutic Mechanisms of Berberine to Improve the Intestinal Barrier Function <i>via</i> Modulating Gut Microbiota, TLR4/NF-κ B/MTORC Pathway and Autophagy in CatsJingWen Cao, MiaoYu Chen, Ran Xu, et al.
Cancer Letters|March 29, 2026
A pan-cancer computational model for predicting immunotherapy response by quantifying tumor immune activityRan Xu, Justin J-L Wong, Yuchen Feng
Behavioral Sciences (Basel, Switzerland)|January 8, 2025
New Communication Technology and the Elderly: A Study on the Continuous Use of the Extreme Edition APP for Middle-Aged and Senior CitizensZeheng Liang, Yixin Xie, Ran Xu, et al.
Frontiers in Immunology|November 29, 2023
Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLCYu Fu, Weichen Duan, Ran Xu, et al.
Cancer Gene Therapy|August 10, 2023
m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1Changkun Huang, Ran Xu, Xuan Zhu, et al.
Pageof 106

Showing results (61-70 of 1,051) with videos related to

Sort By:
Pageof 106
Aging|March 13, 2021
A novel protein ubiquitination-related five-gene signature predicts overall survival in patients with lung adenocarcinomaRan Xu, Tong Lu, Jun Wang, et al.
The Canadian Journal of Cardiology|May 13, 2021
IL-18 Promotes Erythrophagocytosis and Erythrocyte Degradation by M1 Macrophages in a Calcific MicroenvironmentRan Xu, Dan Zhu, Jianghong Guo, et al.
Plos One|November 16, 2017
The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysisYingcheng Wu, Ran Xu, Keren Jia, et al.
Frontiers in Immunology|October 18, 2023
Effects of inflammation on myopia: evidence and potential mechanismsRan Xu, Jing Zheng, Longqian Liu, et al.
Frontiers in Cellular and Infection Microbiology|October 13, 2012
Human gut microbiota: dysbiosis and manipulationDongqian Shen, Chuan Liu, Ran Xu, et al.
Frontiers in Microbiology|August 8, 2022
Therapeutic Mechanisms of Berberine to Improve the Intestinal Barrier Function <i>via</i> Modulating Gut Microbiota, TLR4/NF-κ B/MTORC Pathway and Autophagy in CatsJingWen Cao, MiaoYu Chen, Ran Xu, et al.
Cancer Letters|March 29, 2026
A pan-cancer computational model for predicting immunotherapy response by quantifying tumor immune activityRan Xu, Justin J-L Wong, Yuchen Feng
Behavioral Sciences (Basel, Switzerland)|January 8, 2025
New Communication Technology and the Elderly: A Study on the Continuous Use of the Extreme Edition APP for Middle-Aged and Senior CitizensZeheng Liang, Yixin Xie, Ran Xu, et al.
Frontiers in Immunology|November 29, 2023
Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLCYu Fu, Weichen Duan, Ran Xu, et al.
Cancer Gene Therapy|August 10, 2023
m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1Changkun Huang, Ran Xu, Xuan Zhu, et al.
Pageof 106